What this study is
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.
What's being tested
- Behavioral Intervention
Intervention · BEHAVIORAL
Complete HOPE-C sessions
- Interview
Intervention · OTHER
Complete interview
- Survey Administration
Intervention · OTHER
Ancillary studies
Study details
- Official title
- Adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout (HOPE-C)
- Sponsor
- Fred Hutchinson Cancer Center
- Conditions
- Ovarian Carcinoma · Psychiatric Disorder
- Enrolling
- 25 people
- Starts
- 2026-02-24
- Est. completion
- 2029-12-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Age 18 years of age or older
- English speaking
- Able to provide informed consent
- Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers [APPs])
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openFred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
- Megan J. Shen, PhD · Contact206-667-4172mshen2@fredhutch.org
- Megan J. Shen, PhD · Principal investigator
Recruiting
Study team
Sponsor
Fred Hutchinson Cancer Center
Study ID RG1125922
Principal investigator
Megan J. Shen, PhD
Fred Hutch/University of Washington Cancer Consortium
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.